Barbara C. Biedermann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Barbara C. Biedermann has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Burkhard Hecker
Bruderholz Hospital, Bruderholz, Switzerland
1 shared publicationC Jeanneret
University Department of Medicine, Kantonsspital, Bruderholz, Switzerland
1 shared publicationC Koella
Department of Surgery, Kantonsspital, Bruderholz, Switzerland
1 shared publicationChristina Jeanneret
Department of Medicine, University Hospital Bruderholz, Bruderholz, Switzerland
1 shared publicationChristoph Koella
Department of Surgery, Cantonal Hospital Bruderholz, Bruderholz, Switzerland
1 shared publication- Emmanouil Kyriakakis
Laboratory for Signal Transduction, Department of Biomedicine, Basel University Hospital, Basel, Switzerland
1 shared publication
Latest Publications
- Open Access
- 2 September 2010
- Published by Wiley in European Journal of Immunology
- Vol. 40 (11) , 3268-3279
Invariant natural killer T cells: Linking inflammation and neovascularization in human atherosclerosis
Atherosclerosis, a chronic inflammatory lipid storage disease of large arteries, is complicated by cardiovascular events usually precipitated by plaque rupture or erosion. Inflammation participates in lesion progression and plaque rupture. Identification of leukocyte populations involved in plaque destabilization is important for effective prevention of cardiovascular events. This study investigates CD1d‐expressing cells and invariant NKT cells (iNKT) in human arterial tissue, their correlation with disease severity and symptoms, and potential mechanisms for their involvement in plaque formation and/or destabilization. CD1d‐expressing cells were present in advanced plaques in patients who suffered from cardiovascular events in the past and were most abundant in plaques with ectopic neovascularization. Confocal microscopy detected iNKT cells in plaques, and plaque‐derived iNKT cell lines promptly produced proinflammatory cytokines when stimulated by CD1d‐expressing APC‐presenting α‐galactosylceramide lipid antigen. Furthermore, iNKT cells were diminished in the circulating blood of patients with symptomatic atherosclerosis. Activated iNKT cell‐derived culture supernatants showed angiogenic activity in a human microvascular endothelial cell line HMEC‐1‐spheroid model of in vitro angiogenesis and strongly activated human microvascular endothelial cell line HMEC‐1 migration. This functional activity was ascribed to IL‐8 released by iNKT cells upon lipid recognition. These findings introduce iNKT cells as novel cellular candidates promoting plaque neovascularization and destabilization in human atherosclerosis.
- 2 September 2010
- Published by Wiley in European Journal of Immunology
- Vol. 40 (11) , 3268-3279
Open AccessInvariant natural killer T cells: Linking inflammation and neovascularization in human atherosclerosis
Atherosclerosis, a chronic inflammatory lipid storage disease of large arteries, is complicated by cardiovascular events usually precipitated by plaque rupture or erosion. Inflammation participates in lesion progression and plaque rupture. Identification of leukocyte populations involved in plaque destabilization is important for effective prevention of cardiovascular events. This study investigates CD1d‐expressing cells and invariant NKT cells (iNKT) in human arterial tissue, their correlation with disease severity and symptoms, and potential mechanisms for their involvement in plaque formation and/or destabilization. CD1d‐expressing cells were present in advanced plaques in patients who suffered from cardiovascular events in the past and were most abundant in plaques with ectopic neovascularization. Confocal microscopy detected iNKT cells in plaques, and plaque‐derived iNKT cell lines promptly produced proinflammatory cytokines when stimulated by CD1d‐expressing APC‐presenting α‐galactosylceramide lipid antigen. Furthermore, iNKT cells were diminished in the circulating blood of patients with symptomatic atherosclerosis. Activated iNKT cell‐derived culture supernatants showed angiogenic activity in a human microvascular endothelial cell line HMEC‐1‐spheroid model of in vitro angiogenesis and strongly activated human microvascular endothelial cell line HMEC‐1 migration. This functional activity was ascribed to IL‐8 released by iNKT cells upon lipid recognition. These findings introduce iNKT cells as novel cellular candidates promoting plaque neovascularization and destabilization in human atherosclerosis.
- 1 July 2010
- Published by Hogrefe Publishing Group in Therapeutische Umschau
- Vol. 67 (7) , 335-340
Molekulare Früherkennung in der Medizin – Konzept, Techniken, Perspektiven
Das Konzept der molekularen Früherkennung hat mit der Entschlüsselung des menschlichen Genoms um die Jahrtausendwende erheblichen Aufschwung bekommen. Technologischer Fortschritt wird in den nächsten Jahren umfangreiche, ja umfassende (komprehensive) molekulargenetische Untersuchungen des Individuums in die Reichweite des diagnostischen Alltags bringen. In gewissen Bereichen der Medizin, z. B. in der Infektiologie oder der Hämato-Onkologie, sind molekulare Diagnosen bereits heute obligater Standard. Im Falle polygenetischer, multifaktoriell bedingter Krankheiten haben molekulargenetische Tests heute jedoch nur in Ausnahmefällen einen klinisch relevanten Stellenwert. Neue Biomarker, meistens Proteine oder Metaboliten, sind nicht selten durch komprehensive, molekulare Verfahren („-omics“) identifiziert worden. Nur die genaue Kenntnis der diagnostischen und prognostischen Aussagekraft und der Limitationen eines molekularen Tests erlaubt seine sinnvolle Anwendung.
- 1 July 2010
- Published by Hogrefe Publishing Group in Therapeutische Umschau
- Vol. 67 (7) , 335-340
Molekulare Früherkennung in der Medizin – Konzept, Techniken, Perspektiven
Das Konzept der molekularen Früherkennung hat mit der Entschlüsselung des menschlichen Genoms um die Jahrtausendwende erheblichen Aufschwung bekommen. Technologischer Fortschritt wird in den nächsten Jahren umfangreiche, ja umfassende (komprehensive) molekulargenetische Untersuchungen des Individuums in die Reichweite des diagnostischen Alltags bringen. In gewissen Bereichen der Medizin, z. B. in der Infektiologie oder der Hämato-Onkologie, sind molekulare Diagnosen bereits heute obligater Standard. Im Falle polygenetischer, multifaktoriell bedingter Krankheiten haben molekulargenetische Tests heute jedoch nur in Ausnahmefällen einen klinisch relevanten Stellenwert. Neue Biomarker, meistens Proteine oder Metaboliten, sind nicht selten durch komprehensive, molekulare Verfahren („-omics“) identifiziert worden. Nur die genaue Kenntnis der diagnostischen und prognostischen Aussagekraft und der Limitationen eines molekularen Tests erlaubt seine sinnvolle Anwendung.
- Open Access
- 29 January 2007
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 94 (4) , 449-456
Selective loss of extracellular matrix proteins is linked to biophysical properties of varicose veins assessed by ultrasonography
Dilatation and enhanced distensibility are specific biophysical properties of varicose veins. Both can be assessed by ultrasonography. The aim of this study was to analyse correlations between the vein wall protein content and these two biophysical properties of varicose veins. Twenty-seven patients having surgery for varicose veins and six control patients with normal veins undergoing arterial bypass surgery were examined clinically and with ultrasonography the day before surgery. Fifty-two varicose and six control vein rings were harvested and analysed histopathologically and morphometrically; vascular tissue microarrays incorporated 116 vein wall sectors. Elastin loss in the adventitia (P = 0·010) and reduction of type III collagen in the intima and media (P = 0·004) were observed in varicose veins. Elastin loss correlated negatively with vein diameter at rest (P = 0·005), whereas loss of type III collagen in the intima correlated negatively with the increase in vein diameter at the Valsalva manoeuvre (P < 0·001). Loss of elastin and type III collagen occurs in varicose veins and can be assessed with ultrasonography in vivo by measuring vein diameter and distensibility.
- 29 January 2007
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 94 (4) , 449-456
Open AccessSelective loss of extracellular matrix proteins is linked to biophysical properties of varicose veins assessed by ultrasonography
Dilatation and enhanced distensibility are specific biophysical properties of varicose veins. Both can be assessed by ultrasonography. The aim of this study was to analyse correlations between the vein wall protein content and these two biophysical properties of varicose veins. Twenty-seven patients having surgery for varicose veins and six control patients with normal veins undergoing arterial bypass surgery were examined clinically and with ultrasonography the day before surgery. Fifty-two varicose and six control vein rings were harvested and analysed histopathologically and morphometrically; vascular tissue microarrays incorporated 116 vein wall sectors. Elastin loss in the adventitia (P = 0·010) and reduction of type III collagen in the intima and media (P = 0·004) were observed in varicose veins. Elastin loss correlated negatively with vein diameter at rest (P = 0·005), whereas loss of type III collagen in the intima correlated negatively with the increase in vein diameter at the Valsalva manoeuvre (P < 0·001). Loss of elastin and type III collagen occurs in varicose veins and can be assessed with ultrasonography in vivo by measuring vein diameter and distensibility.
- 1 March 2006
- Published by Hogrefe Publishing Group in Therapeutische Umschau
- Vol. 63 (3) , 217-220
Perkutane transluminale Angioplastie – symptomatische oder kausale Therapie?
Die perkutane, transluminale Koronarangioplastie ist eine minimal invasive, kausale Therapie einer Koronarstenose oder eines akuten Koronarverschlusses, nicht aber der Arteriosklerose als panarterieller Krankheit. Die präzise, möglichst molekulare Charakterisierung des pathogenen Prozesses und die entsprechende Typisierung der Arteriosklerose beim einzelnen Patienten ist die Voraussetzung für eine gezielte und wirksame, d.h. remissionsinduzierende Therapie. Und manchmal sind dies sogar kausale Therapien. Erste Ansätze derartiger zielgerichteter («targeted») Behandlungsformen unterziehen sich zur Zeit der Endpunkt-kontrollierten, klinischen Prüfung.
- 1 March 2006
- Published by Hogrefe Publishing Group in Therapeutische Umschau
- Vol. 63 (3) , 217-220
Perkutane transluminale Angioplastie – symptomatische oder kausale Therapie?
Die perkutane, transluminale Koronarangioplastie ist eine minimal invasive, kausale Therapie einer Koronarstenose oder eines akuten Koronarverschlusses, nicht aber der Arteriosklerose als panarterieller Krankheit. Die präzise, möglichst molekulare Charakterisierung des pathogenen Prozesses und die entsprechende Typisierung der Arteriosklerose beim einzelnen Patienten ist die Voraussetzung für eine gezielte und wirksame, d.h. remissionsinduzierende Therapie. Und manchmal sind dies sogar kausale Therapien. Erste Ansätze derartiger zielgerichteter («targeted») Behandlungsformen unterziehen sich zur Zeit der Endpunkt-kontrollierten, klinischen Prüfung.
- 1 March 2006
- Published by Wiley in Arthritis & Rheumatism
- Vol. 54 (3) , 908-913
Acute occlusive large vessel disease leading to fatal stroke in a patient with systemic lupus erythematosus: Arteritis or atherosclerosis?
A woman with a history of systemic lupus erythematosus presented with extensive bilateral strokes due to acute inflammatory, occlusive large vessel disease affecting several aortic branches including the carotid, subclavian, renal, and iliac arteries. We quantitatively characterized the arterial inflammation in this patient and compared it with the inflammatory infiltrates from 22 patients with conventional atherosclerosis. Profound histomorphologic differences from conventional atherosclerosis (predominance of CD8-positive lymphocytes, relative absence of macrophages, no ectopic neovascularization, no signs of plaque hemorrhage, concentric instead of eccentrical stenosis) suggest that this patient's accelerated arteriopathy was precipitated by pathogenic events other than conventional atherosclerosis.
- 1 March 2006
- Published by Wiley in Arthritis & Rheumatism
- Vol. 54 (3) , 908-913
Acute occlusive large vessel disease leading to fatal stroke in a patient with systemic lupus erythematosus: Arteritis or atherosclerosis?
A woman with a history of systemic lupus erythematosus presented with extensive bilateral strokes due to acute inflammatory, occlusive large vessel disease affecting several aortic branches including the carotid, subclavian, renal, and iliac arteries. We quantitatively characterized the arterial inflammation in this patient and compared it with the inflammatory infiltrates from 22 patients with conventional atherosclerosis. Profound histomorphologic differences from conventional atherosclerosis (predominance of CD8-positive lymphocytes, relative absence of macrophages, no ectopic neovascularization, no signs of plaque hemorrhage, concentric instead of eccentrical stenosis) suggest that this patient's accelerated arteriopathy was precipitated by pathogenic events other than conventional atherosclerosis.
- Open Access
- 27 October 2004
- Published by CLOCKSS Archive in Swiss Medical Forum ‒ Schweizerisches Medizin-Forum
- Vol. 4 (44) , 1120-1121
Die rekombinante DNA-Technologie 6: Polymerase-Kettenreaktion - die exponentielle Vermehrung der DNA
- 27 October 2004
- Published by CLOCKSS Archive in Swiss Medical Forum ‒ Schweizerisches Medizin-Forum
- Vol. 4 (44) , 1120-1121
Open AccessDie rekombinante DNA-Technologie 6: Polymerase-Kettenreaktion - die exponentielle Vermehrung der DNA
- 1 October 2003
- Published by Hogrefe Publishing Group in Praxis
- Vol. 92 (42) , 1781-1783
Arteriosklerose – eine Autoimmunkrankheit?
Angesichts der hohen Prävalenz der klinisch aktiven Arteriosklerose und des – gerade bei alten Patienten – invalidisierenden Charakters ihrer Komplikationen, wäre eine effizientere Behandlungsmöglichkeit der Arteriosklerose dringend erwünscht. Therapieansätze, die die Arteriosklerose als Autoimmunkrankheit angehen, haben sich im Tierexperiment als vielversprechend herausgestellt und es bleibt zu hoffen, dass sie sich bald auch in klinischen Studien am Menschen bewähren werden.
- 1 October 2003
- Published by Hogrefe Publishing Group in Praxis
- Vol. 92 (42) , 1781-1783
Arteriosklerose – eine Autoimmunkrankheit?
Angesichts der hohen Prävalenz der klinisch aktiven Arteriosklerose und des – gerade bei alten Patienten – invalidisierenden Charakters ihrer Komplikationen, wäre eine effizientere Behandlungsmöglichkeit der Arteriosklerose dringend erwünscht. Therapieansätze, die die Arteriosklerose als Autoimmunkrankheit angehen, haben sich im Tierexperiment als vielversprechend herausgestellt und es bleibt zu hoffen, dass sie sich bald auch in klinischen Studien am Menschen bewähren werden.
- 28 December 1999
- Vol. 129, 1993-5
[Molecular medicine reaches adulthood in 1999: from the search for the needle in the haystack to genome navigation].
- 28 December 1999
- Vol. 129, 1993-5
[Molecular medicine reaches adulthood in 1999: from the search for the needle in the haystack to genome navigation].